Amgen 2012 Annual Report Download - page 129

Download and view the complete annual report

Please find page 129 of the 2012 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 150

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150

F-30
13. Accrued liabilities
Accrued liabilities consisted of the following as of December 31, 2012 and 2011 (in millions):
2012 2011
Sales deductions $ 1,129 $ 1,326
Employee compensation and benefits 1,010 916
Sales returns reserve 346 339
Legal reserve 780
Other 2,306 1,667
Total accrued liabilities $ 4,791 $ 5,028
14. Financing arrangements
The carrying values and the fixed contractual coupon rates of our long-term borrowings were as follows as of December 31,
2012 and 2011 (in millions):
2012 2011
0.375% convertible notes due 2013 (0.375% 2013 Convertible Notes) $ 2,488 $ 2,346
1.875% notes due 2014 (1.875% 2014 Notes) 1,000 1,000
4.85% notes due 2014 (4.85% 2014 Notes) 1,000 1,000
2.30% notes due 2016 (2.30% 2016 Notes) 749 748
2.50% notes due 2016 (2.50% 2016 Notes) 999 999
2.125% notes due 2017 (2.125% 2017 Notes) 1,248
5.85% notes due 2017 (5.85% 2017 Notes) 1,099 1,099
6.15% notes due 2018 (6.15% 2018 Notes) 499 499
4.375% euro denominated notes due 2018 (4.375% 2018 euro Notes) 723 714
5.70% notes due 2019 (5.70% 2019 Notes) 999 998
2.125% euro denominated notes due 2019 (2.125% 2019 euro Notes) 887
4.50% notes due 2020 (4.50% 2020 Notes) 300 300
3.45% notes due 2020 (3.45% 2020 Notes) 897 897
4.10% notes due 2021 (4.10% 2021 Notes) 998 998
3.875% notes due 2021 (3.875% 2021 Notes) 1,745 1,745
3.625% notes due 2022 (3.625% 2022 Notes) 747
5.50% pound sterling denominated notes due 2026 (5.50% 2026 pound sterling Notes) 763 739
4.00% pound sterling denominated notes due 2029 (4.00% 2029 pound sterling Notes) 1,117
6.375% notes due 2037 (6.375% 2037 Notes) 899 899
6.90% notes due 2038 (6.90% 2038 Notes) 499 499
6.40% notes due 2039 (6.40% 2039 Notes) 996 996
5.75% notes due 2040 (5.75% 2040 Notes) 697 697
4.95% notes due 2041 (4.95% 2041 Notes) 595 595
5.15% notes due 2041 (5.15% 2041 Notes) 2,232 2,232
5.65% notes due 2042 (5.65% 2042 Notes) 1,244 1,244
5.375% notes due 2043 (5.375% 2043 Notes) 1,000
Other, including our zero-coupon convertible notes 109 184
Total debt 26,529 21,428
Less current portion (2,495)(84)
Total noncurrent debt $ 24,034 $ 21,344
Debt repayments
During the year ended December 31, 2012, we repaid $123 million of debt, including the redemption of all of our outstanding
zero-coupon convertible notes due in 2032 and debt assumed in the acquisition of MN and deCODE. In February 2011, our 0.125%